Table 3.
LVSP, mmHg | +dP/dt, mmHg/s | −dP/dt, mmHg/s | CF, ml/min | |
---|---|---|---|---|
Baseline | 89 ± 3 | 3,140 ± 286 | −1,983 ± 117 | 2.5 ± 0.2 |
100 nM BAY 60-6583 | 88 ± 3 | 3,177 ± 294 | −1,996 ± 126 | 2.5 ± 0.2 |
500 nM BAY 60-6583 | 88 ± 3 | 3,184 ± 309 | −2,007 ± 117 | 2.5 ± 0.2 |
1000 nM BAY 60-6583 | 90 ± 3 | 3,321 ± 376 | −2,116 ± 163 | 2.6 ± 0.3 |
Values are means ± SE. Baseline values were taken before treatment with the A2bAR agonist BAY 60-6583.